Stay updated on ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial

Sign up to get notified when there's something new on the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The website has added information about three new interventions/treatments and updated the study to include 65 locations, while also revising to version 2.10.0 from the previous version 2.9.7.
    Difference
    0.5%
    Check dated 2024-07-23T14:38:30.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T08:13:19.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-07-02T14:39:45.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-27T10:31:58.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-26T09:25:43.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value 'Show more Revision: v2.9.0' has recently changed to 'Drug Information available for: Bevacizumab FDA Drug and Device Resources'. This change likely indicates an update or revision in the drug information available for Bevacizumab in the study.
    Difference
    33%
    Check dated 2024-06-25T08:33:01.000Z thumbnail image

Stay in the know with updates to ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page.